Last 7 days
-21.8%
Last 30 days
-27.1%
Last 90 days
-44.9%
Trailing 12 Months
-77.6%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
JNJ | 404.8B | 94.9B | -5.16% | -10.64% | 22.56 | 4.26 | 1.25% | -14.07% |
LLY | 296.8B | 28.5B | -5.67% | 20.74% | 47.53 | 10.4 | 0.79% | 11.88% |
MRK | 272.8B | 59.3B | -1.75% | 40.02% | 17.88 | 4.63 | 21.72% | 11.27% |
PFE | 226.4B | 100.3B | -8.43% | -20.95% | 7.22 | 2.26 | 23.43% | 42.74% |
BMY | 142.7B | 46.2B | -7.78% | -1.12% | 22.55 | 3.09 | -0.49% | -9.54% |
MID-CAP | ||||||||
PRGO | 4.8B | 4.5B | -0.20% | -5.41% | -34.17 | 1.08 | 7.56% | -104.06% |
RETA | 3.3B | 2.2M | 105.10% | 171.03% | -10.52 | 1.5K | -80.71% | -4.88% |
SMALL-CAP | ||||||||
SUPN | 1.9B | 667.2M | -9.96% | 17.66% | 31.57 | 2.87 | 15.09% | 13.64% |
TLRY | 1.6B | 602.5M | -17.77% | -52.80% | -2.74 | 2.63 | 18.18% | -18.59% |
CGC | 991.7M | 478.9M | -11.35% | -65.42% | -0.32 | 2.07 | -31.50% | -634.70% |
INVA | 792.9M | 285.2M | -7.22% | -37.95% | 3.6 | 2.78 | -27.21% | -40.28% |
CRON | 768.8M | 114.5M | -15.28% | -37.42% | -4.56 | 6.72 | 27.90% | 57.40% |
PAHC | 612.8M | 972.1M | -6.94% | -26.30% | 16.32 | 0.63 | 10.54% | -19.02% |
OPNT | 106.7M | - | 2.08% | -28.79% | -3.22 | 2.72 | 4.98% | -2206.89% |
TXMD | 32.7M | 87.5M | -27.15% | -77.57% | -3.77 | 0.37 | -3.70% | 94.95% |
Income Statement (Last 12 Months) | ||||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 |
Revenue | -4.9% | 87,489,000 | 91,978,000 | 86,418,000 | 86,951,000 | 90,851,000 |
Gross Profit | -4.1% | 69,364,000 | 72,359,000 | 67,407,000 | 68,113,000 | 71,169,000 |
Operating Expenses | -11.5% | 170,573,000 | 192,742,000 | 204,128,000 | 207,883,000 | 210,154,000 |
S&GA Expenses | -11.5% | 83,705,000 | 94,581,000 | 103,066,000 | 108,195,000 | 112,189,000 |
R&D Expenses | -8.2% | 5,512,000 | 6,005,000 | 6,436,000 | 7,086,000 | 8,060,000 |
EBITDA | 82.5% | 34,325,000 | 18,810,000 | -142,449,000 | -135,405,000 | - |
EBITDA Margin | 91.8% | 0.39 | 0.20 | -1.65 | -1.56 | - |
Earnings Before Taxes | 68.5% | -8,375,000 | -26,570,000 | -182,053,000 | -172,415,000 | -171,542,000 |
EBT Margin | 66.9% | -0.10 | -0.29 | -2.11 | -1.98 | - |
Interest Expenses | -6.5% | 38,517,000 | 41,202,000 | 37,102,000 | 32,917,000 | 32,953,000 |
Net Income | 68.0% | -8,665,000 | -27,120,000 | -182,053,000 | -172,415,000 | -171,542,000 |
Net Income Margin | 66.4% | -0.10 | -0.29 | -2.11 | -1.98 | - |
Free Cahsflow | 15.7% | -103,429,000 | -122,661,000 | -133,852,000 | -142,727,000 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 |
Assets | -8.4% | 134 | 146 | 133 | 169 | 210 |
Current Assets | -11.3% | 87.00 | 99.00 | 84.00 | 119 | 160 |
Cash Equivalents | 2.1% | 38.00 | 38.00 | 30.00 | 65.00 | 105 |
Inventory | 9.0% | 7.00 | 6.00 | 9.00 | 8.00 | 7.00 |
Net PPE | -22.4% | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Liabilities | 5.8% | 182 | 172 | 274 | 263 | 267 |
Current Liabilities | 6.1% | 174 | 164 | 265 | 253 | 86.00 |
Long Term Debt | 3.1% | 94.00 | 91.00 | 203 | 188 | 187 |
LT Debt, Current | 3.1% | 94.00 | 91.00 | 203 | 188 | 15.00 |
LT Debt, Non Current | -100.0% | - | 172 | - | - | - |
Retained Earnings | -2.9% | -1,017 | -988 | -1,100 | -1,051 | -1,008 |
Additional Paid-In Capital | 0.7% | 969 | 962 | 960 | 958 | 951 |
Shares Outstanding | 6.9% | 9.00 | 9.00 | 9.00 | 9.00 | 8.00 |
Cashflow (Last 12 Months) | (In Thousands) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 |
Cashflow From Operations | 15.7% | -103,408 | -122,711 | -133,839 | -142,693 | -133,492 |
Share Based Compensation | -17.7% | 13,933 | 16,939 | 17,230 | 18,125 | 14,956 |
Cashflow From Investing | 0.1% | 140,802 | 140,651 | -1,997 | -2,223 | -1,203 |
Cashflow From Financing | -13.2% | -103,905 | -91,811 | 28,603 | 129,552 | 159,902 |
100%
97.7%
86.5%
Y-axis is the maximum loss one would have experienced if TherapeuticsMD was unfortunately bought at previous high price.
-27.0%
-47.0%
-57.5%
-63.4%
FIve years rolling returns for TherapeuticsMD.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-02-21 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | unchanged | - | -212 | 788 | -% |
2023-02-16 | HARBOUR INVESTMENTS, INC. | unchanged | - | 45.00 | 45.00 | -% |
2023-02-15 | Tejara Capital Ltd | new | - | 1,773,780 | 1,773,780 | 1.02% |
2023-02-15 | Steward Partners Investment Advisory, LLC | unchanged | - | 73.00 | 73.00 | -% |
2023-02-15 | Financial Gravity Asset Management, Inc. | new | - | 1.00 | 1.00 | -% |
2023-02-15 | State of Wyoming | sold off | -100 | -58,000 | - | -% |
2023-02-15 | HOWE & RUSLING INC | sold off | -100 | - | - | -% |
2023-02-14 | AMERIPRISE FINANCIAL INC | reduced | -0.04 | -23,000 | 126,000 | -% |
2023-02-14 | MONEY CONCEPTS CAPITAL CORP | new | - | 39.00 | 39.00 | -% |
2023-02-14 | STATE STREET CORP | new | - | 148,303 | 148,303 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Aug 30, 2022 | rubric capital management lp | 18.27% | 1,721,953 | SC 13D/A | |
Jul 08, 2022 | blackrock inc. | 1.4% | 122,138 | SC 13G/A | |
Jun 03, 2022 | beryl capital management llc | 1.5% | 126,229 | SC 13G | |
Mar 23, 2022 | smith robert j | 5.38% | 23,103,292 | SC 13D/A | |
Feb 14, 2022 | price t rowe associates inc /md/ | 0.1% | 649,807 | SC 13G/A | |
Feb 01, 2022 | blackrock inc. | 5.9% | 24,894,812 | SC 13G/A | |
Jul 07, 2021 | flynn james e | 4.90% | 20,662,810 | SC 13G | |
Feb 16, 2021 | price t rowe associates inc /md/ | 6.2% | 18,869,212 | SC 13G/A | |
Feb 10, 2021 | vanguard group inc | 4.39% | 13,165,644 | SC 13G/A | |
Feb 08, 2021 | fmr llc | - | 0 | SC 13G/A |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | - - | - - | 1.02 -70.43% | 7.32 112.17% | 17.18 397.97% |
Current Inflation | - - | - - | 0.38 -88.99% | 5.84 69.28% | 14.34 315.65% |
Very High Inflation | - - | - - | - - | 4.09 18.55% | 11.00 218.84% |
Date Filed | Form Type | Document | |
---|---|---|---|
Feb 27, 2023 | 8-K | Current Report | |
Feb 23, 2023 | 4 | Insider Trading | |
Feb 23, 2023 | 4 | Insider Trading | |
Feb 22, 2023 | 4/A | Insider Trading | |
Feb 13, 2023 | 5 | Insider Trading | |
Jan 30, 2023 | 4 | Insider Trading | |
Jan 25, 2023 | 4 | Insider Trading | |
Jan 18, 2023 | 8-K | Current Report | |
Jan 12, 2023 | 8-K | Current Report | |
Jan 06, 2023 | 8-K/A | Current Report |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-01-27 | Donegan Michael C | sold | -249 | 5.09 | -49.00 | prin. fin. and acctg. officer |
2023-01-26 | Donegan Michael C | acquired | - | - | 5,940 | prin. fin. and acctg. officer |
2023-01-26 | Donegan Michael C | sold | -8,371 | 5.0796 | -1,648 | prin. fin. and acctg. officer |
2023-01-24 | Donegan Michael C | sold | -37.1707 | 5.3101 | -7.00 | prin. fin. and acctg. officer |
2023-01-23 | Donegan Michael C | sold | -6,950 | 5.3383 | -1,302 | prin. fin. and acctg. officer |
2023-01-23 | Donegan Michael C | acquired | - | - | 4,365 | prin. fin. and acctg. officer |
2022-12-30 | Rubric Capital Management LP | sold | -38,657,000 | 1,333 | -29,000 | - |
2022-12-30 | Rubric Capital Management LP | back to issuer | -38,657,000 | 1,333 | -29,000 | - |
2022-12-09 | Rubric Capital Management LP | bought | 90,284 | 6.09 | 14,825 | - |
2022-12-09 | Bernick Brian | sold | -2,019 | 6.3121 | -320 | co-chief executive officer |
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands | 3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Total revenue, net | $ 20,917,000 | $ 25,406,000 | $ 68,811,000 | $ 68,273,000 |
Cost of goods sold | 3,788,000 | 5,282,000 | 13,388,000 | 14,101,000 |
Total gross profit | 17,129,000 | 20,124,000 | 55,423,000 | 54,172,000 |
Operating expenses: | ||||
Selling and marketing | 19,129,000 | 30,005,000 | 61,703,000 | 86,193,000 |
General and administrative | 17,635,000 | 28,435,000 | 55,445,000 | 66,691,000 |
Research and development | 1,112,000 | 1,605,000 | 4,092,000 | 5,666,000 |
Total operating expenses | 37,876,000 | 60,045,000 | 121,240,000 | 158,550,000 |
Loss from operations | (20,747,000) | (39,921,000) | (65,817,000) | (104,378,000) |
Other (expense) income: | ||||
Gain on sale of business | 143,384,000 | |||
Expense for accretion of Mandatory Redeemable Preferred Stock | (3,457,000) | (3,457,000) | ||
Fair value loss on Lender Warrants derivative liability | (76,000) | (76,000) | ||
Loss on extinguishment of debt | (8,380,000) | |||
Interest expense and other financing costs | (4,833,000) | (7,518,000) | (30,941,000) | (25,341,000) |
Other (expense) income, net | (112,000) | 19,000 | (128,000) | 264,000 |
Total other (expense) income, net | (8,478,000) | (7,499,000) | 100,402,000 | (25,077,000) |
(Loss) income before income taxes | (29,225,000) | (47,420,000) | 34,585,000 | (129,455,000) |
(Benefit) provision for income taxes | (260,000) | 0 | 290,000 | 0 |
Net (loss) income | $ (28,965,000) | $ (47,420,000) | $ 34,295,000 | $ (129,455,000) |
(Loss) earnings per common share, basic | $ (3.13) | $ (5.62) | $ 3.86 | $ (16.68) |
Weighted average common shares, basic | 9,261 | 8,444 | 8,877 | 7,762 |
(Loss) earnings per common share, diluted | $ (3.13) | $ (5.62) | $ 3.73 | $ (16.68) |
Weighted average common shares, diluted | 9,261 | 8,444 | 9,205 | 7,762 |
Comprehensive (loss) income: | ||||
Net (loss) income | $ (28,965,000) | $ (47,420,000) | $ 34,295,000 | $ (129,455,000) |
Comprehensive (loss) income | (28,965,000) | (47,420,000) | 34,295,000 | (129,455,000) |
Product [Member] | ||||
Total revenue, net | $ 20,917,000 | 24,456,000 | 68,327,000 | 67,039,000 |
License and Service [Member] | ||||
Total revenue, net | $ 950,000 | $ 484,000 | $ 1,234,000 |
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Sep. 30, 2022 | Dec. 31, 2021 |
---|---|---|
Current assets: | ||
Cash | $ 27,080 | $ 65,122 |
Restricted cash | 11,250 | |
Accounts receivable, net of allowance for credit losses of $1,621 and $1,334 as of September 30, 2022 and December 31, 2021, respectively | 32,157 | 36,176 |
Inventory | 6,701 | 7,622 |
Prepaid and other current assets | 10,290 | 10,548 |
Total current assets | 87,478 | 119,468 |
Fixed assets, net | 551 | 1,199 |
License rights and other intangible assets, net | 37,876 | 40,318 |
Right of use assets | 7,749 | 8,234 |
Other non-current assets | 253 | 253 |
Total assets | 133,907 | 169,472 |
Current liabilities: | ||
Debt, net | 93,602 | 188,269 |
Lender Warrants derivative liability | 2,058 | |
Make-whole payment derivative liability | 1,751 | |
Mandatory Redeemable Preferred Stock | 19,709 | |
Accounts payable | 13,383 | 20,318 |
Accrued expenses and other current liabilities | 43,568 | 44,304 |
Total current liabilities | 174,071 | 252,891 |
Operating lease liabilities | 7,553 | 8,063 |
Other non-current liabilities | 554 | 2,139 |
Total liabilities | 182,178 | 263,093 |
Commitments and contingencies (Note 9) | ||
Stockholders' deficit: | ||
Preferred stock, par value $0.001; 10,000 shares authorized, 22 issued and included in liabilities due to their redemption provisions | ||
Common stock, par value $0.001; 12,000 shares authorized, 9,467 and 8,598 (adjusted for the 50-for-1 reverse stock split) shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively | 9 | 9 |
Additional paid-in capital | 968,785 | 957,730 |
Accumulated deficit | (1,017,065) | (1,051,360) |
Total stockholders' deficit | (48,271) | (93,621) |
Total liabilities and stockholders' deficit | $ 133,907 | $ 169,472 |